An analysis of renal function in pancreas-kidney and diabetic kidney-alone recipients at two years following transplantation

Soliman El-Gebely, Donna Hathaway, Debra S. Elmer, Lillian W. Gaber, Sergio Acchiardo, A. Osama Gaber

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Pancreas-kidney recipients (SPK) are at higher risk for rejection than diabetic kidney-alone recipients (KA), and thus generally receive higher doses of maintenance immunosuppression. This has lead to concern that the potential benefits to renal function, brought about by posttransplant euglycemia, may be negated by the nephrotoxicity of immunosuppression. We therefore sought to compare patterns of renal function in diabetic patients following SPK and KA transplantation. Serum creatinine levels, corrected glomerular filtration rates (cGFR), and whole blood TDX cyclosporine levels were recorded on 25 SPK and 17 KA at 3, 6, 12, and 24 months posttransplant when patients were free of acute renal dysfunction. The SPK recipients had significantly higher cyclosporine levels at each of the measurement points as compared with the KA recipients (P≤.01). In spite of these higher cyclosporine levels, the SPK recipients showed stable creatinine and cGFR levels throughout the study, as did the KA group until 24 months. At 24 months, the KA group experienced a rise in creatinine from 1.3±.09 ng/dl at 3 months to 1.6±.07 ng/dl at 24 months (P≤0.006). Urine albumin excretion was examined at 24 months, and 6 of 8 KA patients found to have abnormally elevated levels compared with only 3 of 9 SPK patients. These findings indicate that SPK recipients experience stable renal function despite significantly higher cyclosporine levels, while KA recipients demonstrate early signs of deteriorating function at the 2-year follow-up.

Original languageEnglish (US)
Pages (from-to)1410-1415
Number of pages6
JournalTransplantation
Volume59
Issue number10
DOIs
StatePublished - Jan 1 1995

Fingerprint

Pancreas
Transplantation
Kidney
Cyclosporine
Creatinine
Glomerular Filtration Rate
Immunosuppression
Albumins
Maintenance
Urine

All Science Journal Classification (ASJC) codes

  • Transplantation

Cite this

An analysis of renal function in pancreas-kidney and diabetic kidney-alone recipients at two years following transplantation. / El-Gebely, Soliman; Hathaway, Donna; Elmer, Debra S.; Gaber, Lillian W.; Acchiardo, Sergio; Gaber, A. Osama.

In: Transplantation, Vol. 59, No. 10, 01.01.1995, p. 1410-1415.

Research output: Contribution to journalArticle

El-Gebely, Soliman ; Hathaway, Donna ; Elmer, Debra S. ; Gaber, Lillian W. ; Acchiardo, Sergio ; Gaber, A. Osama. / An analysis of renal function in pancreas-kidney and diabetic kidney-alone recipients at two years following transplantation. In: Transplantation. 1995 ; Vol. 59, No. 10. pp. 1410-1415.
@article{a9a6f3dc83c541a8a60992f509926208,
title = "An analysis of renal function in pancreas-kidney and diabetic kidney-alone recipients at two years following transplantation",
abstract = "Pancreas-kidney recipients (SPK) are at higher risk for rejection than diabetic kidney-alone recipients (KA), and thus generally receive higher doses of maintenance immunosuppression. This has lead to concern that the potential benefits to renal function, brought about by posttransplant euglycemia, may be negated by the nephrotoxicity of immunosuppression. We therefore sought to compare patterns of renal function in diabetic patients following SPK and KA transplantation. Serum creatinine levels, corrected glomerular filtration rates (cGFR), and whole blood TDX cyclosporine levels were recorded on 25 SPK and 17 KA at 3, 6, 12, and 24 months posttransplant when patients were free of acute renal dysfunction. The SPK recipients had significantly higher cyclosporine levels at each of the measurement points as compared with the KA recipients (P≤.01). In spite of these higher cyclosporine levels, the SPK recipients showed stable creatinine and cGFR levels throughout the study, as did the KA group until 24 months. At 24 months, the KA group experienced a rise in creatinine from 1.3±.09 ng/dl at 3 months to 1.6±.07 ng/dl at 24 months (P≤0.006). Urine albumin excretion was examined at 24 months, and 6 of 8 KA patients found to have abnormally elevated levels compared with only 3 of 9 SPK patients. These findings indicate that SPK recipients experience stable renal function despite significantly higher cyclosporine levels, while KA recipients demonstrate early signs of deteriorating function at the 2-year follow-up.",
author = "Soliman El-Gebely and Donna Hathaway and Elmer, {Debra S.} and Gaber, {Lillian W.} and Sergio Acchiardo and Gaber, {A. Osama}",
year = "1995",
month = "1",
day = "1",
doi = "10.1097/00007890-199505270-00009",
language = "English (US)",
volume = "59",
pages = "1410--1415",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - An analysis of renal function in pancreas-kidney and diabetic kidney-alone recipients at two years following transplantation

AU - El-Gebely, Soliman

AU - Hathaway, Donna

AU - Elmer, Debra S.

AU - Gaber, Lillian W.

AU - Acchiardo, Sergio

AU - Gaber, A. Osama

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Pancreas-kidney recipients (SPK) are at higher risk for rejection than diabetic kidney-alone recipients (KA), and thus generally receive higher doses of maintenance immunosuppression. This has lead to concern that the potential benefits to renal function, brought about by posttransplant euglycemia, may be negated by the nephrotoxicity of immunosuppression. We therefore sought to compare patterns of renal function in diabetic patients following SPK and KA transplantation. Serum creatinine levels, corrected glomerular filtration rates (cGFR), and whole blood TDX cyclosporine levels were recorded on 25 SPK and 17 KA at 3, 6, 12, and 24 months posttransplant when patients were free of acute renal dysfunction. The SPK recipients had significantly higher cyclosporine levels at each of the measurement points as compared with the KA recipients (P≤.01). In spite of these higher cyclosporine levels, the SPK recipients showed stable creatinine and cGFR levels throughout the study, as did the KA group until 24 months. At 24 months, the KA group experienced a rise in creatinine from 1.3±.09 ng/dl at 3 months to 1.6±.07 ng/dl at 24 months (P≤0.006). Urine albumin excretion was examined at 24 months, and 6 of 8 KA patients found to have abnormally elevated levels compared with only 3 of 9 SPK patients. These findings indicate that SPK recipients experience stable renal function despite significantly higher cyclosporine levels, while KA recipients demonstrate early signs of deteriorating function at the 2-year follow-up.

AB - Pancreas-kidney recipients (SPK) are at higher risk for rejection than diabetic kidney-alone recipients (KA), and thus generally receive higher doses of maintenance immunosuppression. This has lead to concern that the potential benefits to renal function, brought about by posttransplant euglycemia, may be negated by the nephrotoxicity of immunosuppression. We therefore sought to compare patterns of renal function in diabetic patients following SPK and KA transplantation. Serum creatinine levels, corrected glomerular filtration rates (cGFR), and whole blood TDX cyclosporine levels were recorded on 25 SPK and 17 KA at 3, 6, 12, and 24 months posttransplant when patients were free of acute renal dysfunction. The SPK recipients had significantly higher cyclosporine levels at each of the measurement points as compared with the KA recipients (P≤.01). In spite of these higher cyclosporine levels, the SPK recipients showed stable creatinine and cGFR levels throughout the study, as did the KA group until 24 months. At 24 months, the KA group experienced a rise in creatinine from 1.3±.09 ng/dl at 3 months to 1.6±.07 ng/dl at 24 months (P≤0.006). Urine albumin excretion was examined at 24 months, and 6 of 8 KA patients found to have abnormally elevated levels compared with only 3 of 9 SPK patients. These findings indicate that SPK recipients experience stable renal function despite significantly higher cyclosporine levels, while KA recipients demonstrate early signs of deteriorating function at the 2-year follow-up.

UR - http://www.scopus.com/inward/record.url?scp=0029037787&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029037787&partnerID=8YFLogxK

U2 - 10.1097/00007890-199505270-00009

DO - 10.1097/00007890-199505270-00009

M3 - Article

VL - 59

SP - 1410

EP - 1415

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 10

ER -